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Respiratory melioidosis is a disease presentation of the biodefense pathogen,
Burkholderia pseudomallei, which is frequently associated with a lethal septicemic spread
of the bacteria. We have recently developed an improved respiratory melioidosis model
to study the pathogenesis of Burkholderia pseudomallei in the lung (intubation-mediated
intratracheal [IMIT] inoculation), which more closely models descriptions of human
melioidosis, including prominent septicemic spread from the lung and reduced
involvement of the upper respiratory tract. We previously demonstrated that the Type 3
Secretion System cluster 3 (T3SS3) is a critical virulence determinant for B. pseudomallei
when delivered directly into the lung. We decided to comprehensively identify all virulence
determinants required for respiratory melioidosis using the Tn-seq phenotypic screen, as
well as to investigate which virulence determinants are required for dissemination to the
liver and spleen. While previous studies have used Tn-seq to identify essential genes for
in vitro cultured B. pseudomallei, this represents the first study to use Tn-seq to identify
genes required for in vivo fitness. Consistent with our previous findings, we identified
T3SS3 as the largest genetic cluster required for fitness in the lung. Furthermore, we
identified capsular polysaccharide and Type 6 Secretion System cluster 5 (T6SS5) as
the two additional major genetic clusters facilitating respiratory melioidosis. Importantly,
Tn-seq did not identify additional, novel large genetic systems supporting respiratory
melioidosis, although these studies identified additional small gene clusters that may
also play crucial roles in lung fitness. Interestingly, other previously identified virulence
determinants do not appear to be required for lung fitness, such as lipopolysaccharide.
The role of T3SS3, capsule, and T6SS5 in lung fitness was validated by competition
studies, but only T3SS3 was found to be important for respiratory melioidosis when
delivered as a single strain challenge, suggesting that competition studies may provide
a higher resolution analysis of fitness factors in the lung. The use of Tn-seq phenotypic
screening also provided key insights into the selective pressure encountered in the liver.
Keywords: respiratory melioidosis, intubation-mediated intratracheal (IMIT) inoculation, mouse infection models,
Tn-seq, type 3 secretion, type 6 secretion, capsular polysaccharide
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INTRODUCTION
Burkholderia pseudomallei, the etiological agent of melioidosis,
is a motile Gram-negative bacterium classified as a Tier 1
Select Agent. While endemic to Southeast Asia and northern
Australia (Cheng and Currie, 2005), an increasing number of
melioidosis cases have been reported in Latin America (Inglis
et al., 2006), the Caribbean (Wiersinga et al., 2006), Africa
(Schweizer et al., 2014) and other tropical regions worldwide
(Cheng and Currie, 2005). The bacterium is an environmental
saprophyte generally found in the soil and water reservoirs in
indigenous areas (Galyov et al., 2010) where it opportunistically
infects an array of plant (Kaestli et al., 2012), animal, and human
hosts (Cheng and Currie, 2005). The most common routes of
infection in humans include percutaneous inoculation, ingestion,
or inhalation of the bacterium from the environment (Brett
and Woods, 2000; Wiersinga et al., 2006; Lazar Adler et al.,
2009). Melioidosis manifestations may include asymptomatic
seroconversion, febrile illness, pneumonia, hepatic and splenic
abscesses, chronic melioidosis and sepsis syndrome (Holden
et al., 2004;Wiersinga et al., 2006; Cheng et al., 2013). Risk factors
associated with melioidosis include diabetes mellitus, alcoholism,
renal failure, and chronic pulmonary disease (Wiersinga et al.,
2006).
Respiratory melioidosis is a disease presentation of high
relevance to both naturally-occurring and biodefense-related
studies; indeed, B. pseudomallei is lung tropic even in cases
of percutaneous inoculation (Currie et al., 2000). Both our
lab and others have previously shown that the nasal cavity
represents the predominant site of B. pseudomallei colonization
in intranasally-inoculated mice (Owen et al., 2009; Warawa
et al., 2011), whereas direct lung instillation of bacteria can
abrogate nasal cavity colonization and the associated central
nervous system involvement (Revelli et al., 2012; Gutierrez
et al., 2015). We have further characterized that lung-specific
instillation of B. pseudomallei results in a shift of moribund
endpoint from a predominant nasal cavity infection in the
intranasal model to a greater bacterial proliferation in the lung
and disseminated spread (Gutierrez et al., 2015), more closely
resembling descriptions of human melioidosis. Furthermore, the
intubation-mediated intratracheal (IMIT) inoculation method
has facilitated the discovery of a spread-deficiency phenotype for
a capsular polysaccharide mutant from the lung (Gutierrez et al.,
2015), which had not been discovered in mice succumbing to
nasal cavity colonization (Warawa et al., 2011), and yet meets
the predicted role for capsule in mediating protection from
complement during dissemination (Reckseidler-Zenteno et al.,
2005). Thus, the IMIT lung-specific melioidosis model has begun
to provide unique insights into the roles of B. pseudomallei
virulence determinants that have not been identified in other
respiratory melioidosis models. We therefore sought to identify
the roles for additional B. pseudomallei virulence determinants
using the IMIT model of lung-specific disease.
Tn-seq is a powerful new tool used to identify a full
repertoire or genes required for an organism’s viability in a
selective environment by combining saturation mutagenesis and
Next Generation Sequencing (Van Opijnen et al., 2009). Recent
Tn-seq studies identified essential genes required to support
in vitro growth for the Burkholderia pseudomallei K96243
strain (Moule et al., 2014) and the closely related Burkholderia
thailandensis E264 strain (Baugh et al., 2013; Gallagher et al.,
2013). These studies identified potential antimicrobial drug
targets in key constituents of metabolic pathways, cell structure
and genes required for nucleotide and amino acid synthesis,
and further estimated that ∼8% of the Burkholderia genome
represent essential genes (Baugh et al., 2013; Moule et al.,
2014). Importantly, Tn-seq has not previously been used to
identify B. pseudomallei genes required to support growth
in the selective pressure of mammalian host tissues. In the
present study, we investigated the potential of Tn-seq to identify
virulence determinants required by B. pseudomallei to colonize
mammalian lungs in a mouse model of respiratory melioidosis
as well as to disseminate to the liver and spleen. These studies
take advantage of our IMIT respiratory melioidosis model to
non-invasively target delivery of a Tn-seq library directly into the
lungs of mice to specifically identify genes supporting pulmonary
disease in the absence of potential interplay between upper and
lower respiratory tract infections.
MATERIALS AND METHODS
Bacterial Strains and Culture
Burkholderia pseudomallei and Escherichia coli strains (Table 1)
were routinely cultured in Lennox Broth (LB) at 37◦C. For
inoculum preparation, B. pseudomallei strains were subcultured
1:25 in dialyzed and chelated Trypticase Soy Broth (TSBDC)
supplemented with 50µM monosodium glutamate from
overnight LB cultures and grown for 3 h at 37◦ C. Antibiotics
were used at the following concentrations when appropriate:
kanamycin (Km), 25µg/mL; polymyxin B (Pm), 50µg/mL;
streptomycin (Sm), 100µg/mL; gentamicin (Gm), 20µg/mL.
Tn-seq Library Preparation
Plasmids used in this study are identified in Table 1. To construct
the transposon delivery vector pSAM-DKm, the mariner-family
transposon, Himar1 C9 transposase and its upstream regulatory
region were PCR amplified from pBTK30 and cloned as a
BamHI restriction fragment into pSAM-Bt to yield pSAM-
DYH. The kanamycin resistance cassette from pEXKm5 was
PCR amplified and inserted into the MfeI and XbaI restriction
sites in place of the erythromycin resistance cassette and
the resulting plasmid, pSAM-DKm was verified by PCR. To
generate the B. pseudomallei Tn-seq library, the E. coli S17-1
strain transformed with pSAM-DKm was conjugated with the
luminescent B. pseudomallei parent strain JW280 for 2 h at 37◦C.
Transposon mutants were selected for on PmKm LB agar plates
and grown at 37◦C for 24 h. A library of 2 × 104 mutants were
pooled, grown in PmKm LB broth with shaking at 37◦C and
cryopreserved.
Ethics and Biosafety Statement
All animal studies were conducted under Biosafety Level 3
conditions using 8–10 week old female albino C57BL/6J mice
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TABLE 1 | Strains and plasmids used in this study.
Strain Description References
S17−1 E. coli conjugation strain, λpir Simon et al., 1983
S17−1/pKAS46−araPtolC lux Bioluminescence allelic exchange construct Warawa et al., 2011
S17−1/pKAS46−1tssC−5 T6SS5 mutant allelic exchange construct This study
DD503 B. pseudomallei 1026b derivative, PmR SmR KmS GmS, lacking AmrAB-OprA efflux pump Moore et al., 1999
DD503 1tssC−5 T6SS5 mutant This study
DD503 1sctUBp3 T3SS3 mutant Warawa and Woods, 2005
JW270 DD503 1wcb capsule mutant Warawa et al., 2009
JW280 DD503::PtolC-luxCDABE Warawa et al., 2011
JW280 1tssC−5 Bioluminescent T6SS5 mutant This study
MGBP001 DD503::PtolC-luxCDABE-Gm This study
MGBP001 1tssC-5 Bioluminescent, GmR T6SS5 mutant This study
MGBP001 1sctUBp3 Bioluminescent, Gm
R T3SS3 mutant This study
MGBP001 1wcb Bioluminescent, GmR capsule mutant This study
Plasmid
pBTK30 Vector containing Himar1 C9 transposase Goodman et al., 2004
pSAM-Bt Tn-seq vector for use in Bacteroides thetaiotaomicron Goodman et al., 2009
pSAM-DYH pSAM_Bt with the transposase from pBTK30 inserted as a BamHI fragment to replace the
native transposase and promoter
Skurnik et al., 2013a
pEXKm5 Gene replacement vector for Burkholderia species López et al., 2009
pSAM-DKm Tn-seq vector This study
pKAS46 Allelic exchange vector providing KmR and SmS in DD503 genetic background Skorupski and Taylor, 1996
pGSV4 Promoterless bioreporter vector harboring luxCDABE operon Gutierrez et al., 2015
pCR®-Blunt II-TOPO Topoisomerase-conjugated cloning vector Invitrogen
pUC19 Cloning vector New England Biolabs
(B6 (Cg)-Tyrc−2J/J, Jackson Laboratories) bred at the University
of Louisville (Protocol Number 11113). These studies were
approved by the University of Louisville Institutional Animal
Care and Use Committee (Protocol numbers 10073 and 13053)
in agreement with NIH guidelines and the “Guide for the Care
and Use of Laboratory Animals” (NRC). University of Louisville
is approved for use of the Tier 1 select agent B. pseudomallei with
continuous registration from the Centers for Disease Control
since 2010.
Tn-seq Screen
A B. pseudomallei Tn-seq library TSBDC culture was washed
into phosphate buffered saline (PBS) and OD600 readings were
used to estimate bacterial concentrations in order to prepare
an inoculum of 104.74 CFU/50µL. A group of three mice
were inoculated with 50µL of bacterial suspension of Tn-seq
library by intubation mediated intratracheal (IMIT) instillation,
as described (Lawrenz et al., 2014). Disease progression
was monitored twice daily by optical diagnostic imaging of
bioluminescent B. pseudomallei until study completion, as
described (Gutierrez et al., 2015). Animals were euthanized at
moribund endpoints (66 h post-infection) and necropsied to
collect lungs, liver and spleen. Tissues were homogenized and
bacteria from these tissues were cultured in LB broth overnight at
37◦C with shaking. Bioluminescence imaging data was processed
as described (Lawrenz et al., 2014).
Chromosomal DNA was purified from triplicate biological
samples, as described (Beji et al., 1987), and pooled for each
tissue. Genomic DNA was digested with the MmeI restriction
enzyme overnight at 37◦C, treated for 20min at 80◦C to
inactivate the enzyme, purified using the QIAquick, PCR
purification kit (Qiagen) according to the manufacturer’s
instructions, and concentrated with a speed vacuum to a final
volume of 30µL. Restricted fragments were separated by
electrophoresis in a 1% agarose gel and fragments corresponding
to 1.2–1.5 Kb were isolated using the QIAquick Gel Extraction
Kit (Qiagen). Fragments were ligated to barcoded double
stranded adaptors using T4 DNA ligase in 50µL reactions
overnight at 16◦C, treated at 65◦C for 10min to inactivate the
ligase, and purified using the QIAquick, PCR purification kit.




GACGCTCTTCCGATCT-3′) primers (Goodman et al., 2009)
using HiFi DNA Polymerase (KAPA Biosystems). Confirmation
of a 125 base pair product was conducted using 1% agarose
gel electrophoresis, and libraries were sequeced using Illumina
50-bp single end sequencing at the Harvard Medical School
Biopolymer Facility. Data was analyzed by sorting based on
barcodes using a custom script in Java Eclipse, then using CLC
Genomics Workbench v. 7.2 for subsequent bioinformatics.
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Reads were trimmed to remove adapter and transposon
sequences and aligned to the B. pseudomallei 1026b genome
using the default settings in the RNA-seq function in CLC.
Reads that mapped to multiple locations were discarded. The
resultant reads were counted and normalized to the reads per
kilobase of transcript per million reads mapped (RPKM) and
compared across sample sites. Significance was assessed using
the On Proportions function of CLC using the Kals’s test option
and the Bonferroni multiple testing correction was applied to the
comparisons. Initially, fold change measurements of less than−3
(reduced in the mouse samples compared to the input pool) with
a Bonferroni-adjusted p-value of less than 0.05 were considered
significant.
Early Dissemination Studies
Early dissemination studies were conducted using the
B. pseudomallei Tn-seq library strain to infect groups of
three animals by IMIT as described above, euthanizing groups
at 6, 12, and 24 h post-infection. Lung, liver and spleen from
individual animals were collected at necropsy, homogenized and
serial diluted for bacterial enumeration as described (Lawrenz
et al., 2014).
Type 6 Secretion System Mutagenesis
To generate a Type 6 Secretion System cluster 5 (T6SS5)
mutant in B. pseudomallei, an internal in-frame 1437 bp
region of the tssC-5 gene was deleted. Briefly, flanking
fragments in the 5′ and 3′ region of the tssC-5 gene





AGCCGCCCGCGAG. The amplified 5′ tssC-5 fragment
was cloned into pSK as an EcoRI/HindIII fragment to yield
pSK-5′tssC. The amplified 3′ tssC-5 fragment was cloned into
pSK-5′tssC as a HindIII/KpnI fragment to yield pSK-1tssC-
5. The assembled fragment was cloned into pKAS46 as an
EcoRI/KpnI fragment to yield pKAS46-1tssC-5 and conjugated
with the parent B. pseudomallei strain DD503. Finally, the
bioluminescent strain JW280 1tssC-5 was constructed by
conjugation of DD503 1tssC-5 with S17-1/pKAS46-araPtolClux,
as described previously (Warawa et al., 2011).
Virulence Assessment of a T6SS5 Mutant
in Respiratory Melioidosis
Animal studies were conducted to compare the virulence of
JW280 and the JW280 1tssC-5 mutant by IMIT infection, as
described above. Groups of five animals were euthanized at
moribund end point defined as loss of righting reflex. Thus, we
define LD50 in our studies as onset of moribund symptoms rather
than to use death as an endpoint. Mice were necropsied and lung,
liver and spleen were isolated and imaged for bioluminescence in
24-well black plates. The equations used to perform correlations
between bioluminescent signal and colony forming units (CFU)
have been previously defined (Gutierrez et al., 2015).
Competition Studies
A gentamicin resistance cassette was amplified with flankingNotI
restriction sites from the pGSV4 vector (Gutierrez et al., 2015)
with the primers Gm cass NotI(+) (GCGGCCGCAGATTTAA
ATTAATTAAGAGCTAGAATTGACATAAGCCTG) and Gm
cass NotI(−) (GAAGCGGCCGCGGCGTTGTGACAATTTACC
GAACAACTC). The Gm cassette was cloned into the pCR R©-
Blunt II-TOPO cloning vector (Invitrogen) and was then cloned
into the pUC19-araPtolClux vector as a NotI/NotI fragment to
yield pUC19-araPtolClux-Gm. The araPtolClux-Gm fragment was
cloned into pKAS46 to generate the pKAS46-araPtolClux-Gm and
was transformed into S17-1 cells to generate the S17-1/pKAS46-
araPtolClux-Gm strain. This strain was conjugated with the
B. pseudomallei parent strain DD503, capsule polysaccharide
mutant (JW270), Type 3 Secretion System translocation-deficient
mutant (DD503 1sctUBp3) and Type 6 Secretion System mutant
(DD503 1tssC-5) to generate MGBP001, MGBP001 1wcb,
MGBP001 1sctUBp3, and MGBP001 1tssC-5, respectively, by
allelic exchange as previously described (Warawa and Woods,
2005).
Competition studies were conducted by challenging animals
by IMIT with ∼104.0 CFU of a 1:1 mixture of non-luminescent
B. pseudomallei DD503 plus one of the four luminescent,
gentamicin-resistantMGBP001 strains. The study was completed
at 67 h post-infection at which point lung, liver and spleen were
isolated and homogenized. Homogenates were plated in replicate
on both LB and LB-Gm plates for bacterial enumeration and
competitive index calculations.
Statistical Analysis
Two-Way ANOVA followed by the Bonferroni post-test,
Student’s T-test, Log-rank survival analysis (Mantel-Cox test
and Gehan-Breslow-Wilcoxon test), One-Way ANOVA followed
by Tukey’s Multiple Comparison test were conducted using
GraphPad Prism.
RESULTS
Lung-specific Mouse Infection with the
Tn-seq Insertion Library
We sought to identify virulence determinants required by
B. pseudomallei to cause disease specifically in the lung,
as well as for subsequent disseminated spread to liver and
spleen. Accordingly, we generated a transposon insertion library
composed of 20,000 insertion mutants in the genome of the
B. pseudomallei luminescent strain JW280, a derivative of the
1026b clinical strain. To select against transposon-inactivated
genes required for lung colonization and systemic spread in vivo,
we challenged pools of C57BL/6J albino female mice with
104.74 CFU of a transposon insertion library. This inoculum
was within 10 median lethal doses (LD50) of the JW280 strain
(Gutierrez et al., 2015), and achieved ∼4x coverage of the
genome and 4x mutant strain representation in the challenge
inoculum. We monitored the growth rate of the mutant library
by bioluminescence starting at 19 h post-infection and observed
that in the lungs, the library pool exhibited logarithmic growth
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at a rate consistent with our previously observed JW280 parent
strain growth rate (Gutierrez et al., 2015; Figure 1A). By
66 h post-infection, all animals had reached moribund stage,
characterized by acute respiratory infection and systemic spread
(Figure 1B) and at this point all animals were euthanized and
lungs, liver and spleen were isolated. These data indicate that
in vivo disease progression in C57BL/6J mice infected with the
transposon insertion library followed an acute course of infection
comparable to that of the parent B. pseudomallei strain (Gutierrez
et al., 2015).
Transposon Insertion Sequencing and
Mapping
We performed sequencing of the input transposon insertion
library to determine transposon insertion density and assess
coverage of the B. pseudomallei JW280 genome. Sequencing of
the input mutant library mapped 1.1268 million reads to the
B. pseudomallei 1026b genome and revealed that 88% percent of
genes contained a transposon insertion. Approximately 8% of the
B. pseudomallei genome is estimated to represent essential genes
FIGURE 1 | In vivo disease progression of Burkholderia pseudomallei
Tn-seq transposon library. (A) In vivo growth of the B. pseudomallei
transposon library in the thoracic cavity of three C57BL/6J female albino mice
infected by IMIT was monitored twice daily with an in vivo imaging system
using luminescence as a read out for bacterial replication. Total luminescence
was enumerated using a region of interest (ROI) centered on the thoracic
cavity. The dashed line indicates technical 95% limit of detection. (B) Whole
body imaging of moribund C57BL/6J mice infected with B. pseudomallei
transposon library at 66 h post-infection. The logarithmic scale bar is provided
for the standardized data presentation of 2.5× 103–3× 104 p/s/cm2/sr.
required for in vitro growth (Moule et al., 2014); thus only 92%
of B. pseudomallei genes can be mutanted and our Tn-seq library
approached full saturation. As expected, larger genes received
better coverage efficiency, corresponding to the random nature of
Marineer transposon insertion events favoring higher frequency
insertion into larger genes (Figure 2A).
Tn-seq analyses typically investigate changes in library
diversity between two conditions using a 2-fold cutoff criteria
for very large libraries investigated in in vitro studies (Skurnik
et al., 2013a,b; Wiles et al., 2013). However, we had limited
the size of our Tn-seq library to achieve a biologically relevant
infection and therefore we increased the stringency of our initial
data analysis to a 3-fold cutoff to account for an increase in
variation noise with a smaller library studied in vivo. Sequencing
of the output libraries showed that at a 3-fold loss relative to the
input library, transposon mutants in the lungs sustained selective
pressure leading to clearance of 1455 transposon-inactivated
genes required for lung colonization relative to the input pool
(Figure 2B and Supplemental Table 1). We hypothesized that
lung-specific delivery of the B. pseudomalleimutant library would
FIGURE 2 | Gene size distribution of the Burkholderia pseudomallei
genome and transposon insertion coverage. (A) Histogram of the B.
pseudomallei genome (green bars) and percentage of genes lacking
transposon insertions (brown bars), both binned at 100bp gene size intervals.
(B) Tn-seq data sets were analyzed for B. pseudomallei Tn-seq mutants lost
by selective pressures in the lung (1455); liver (765); spleen (2862) at a 3-fold
reduction in relative abundance relative to the input pool. Venn diagram
illustrating mutants lost in the three tissues, with 454 genes being selected
against in all three tissues.
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sustain selective pressure in the lung, which would lead to an
initial loss of library diversity and subsequent additional diversity
loss following spread to the liver and spleen. As expected, the
transposon library was further reduced in the spleen (2862 total
genes lost relative to input pool), suggestive of loss of library
diversity both in the lung and due to loss of genes required
for disseminated spread. Surprisingly, we observed a greater
retention of diversity of the transposon library in the liver relative
to the lung (765 mutants lost in the liver compared to 1455 in
the lung), suggesting that a representative library pool reached
this site prior to effects of the selective pressure exhibited in
the lung (Figure 2B). Further, the retention of library diversity
in the liver relative to the lung suggests that the liver does not
exhibit as strong a selective environment as the lung, and that the
early spread to the liver is at high titer so as to avoid potential
bottlenecking effects of spread from one tissue to another. Taken
together, these data suggest that B. pseudomallei spread from the
lung to the liver is a prominent dissemination path which occurs
as an early event, resulting in a reduced selective pressure in the
liver.
Burkholderia pseudomallei Early Hepatic
Dissemination
To characterize the kinetics of disseminated spread from the lung
to other tissues, a time course analysis was conducted. Groups
of three C57BL/6J female albino mice were infected with 104.62
CFU of the Tn-seq library, and then lungs, liver and spleen
were isolated at 6, 12, and 24 h post-infection and bacterial titers
were enumerated from each organ. By 6 h post-infection, bacteria
were cultured from the lungs with 5.5-fold higher titers than the
original instilled amount and grew exponentially throughout the
course of infection (Figure 3), consistent with growth patterns
observed by optical diagnostic imaging (Figure 1A). At 6 h post-
infection, 104.87 CFU were also present in the liver, which were
similar titers to those found in the lungs (Figure 3), confirming
the indications of the Tn-seq data that hepatic spread is early and
at high titer. Colonization of the spleen by 12 h post-infection was
at or below the limit of detection (100 CFU), where pronounced
splenic colonization only occurred 24 h post-infection (Figure 3),
suggesting that the enhanced loss of Tn-seq library diversity in
the spleen relative to the lung is associated with later spread
from the lung, subsequent to the effects of selective pressure in
the lung. Thus, B. pseudomallei colonizes host lungs very early
during infection and persists at this site through the onset of
acute respiratory disease. Similarly, the bacterium can spread
from the lungs at high titer to colonize the host liver very
early following infection but bacterial titers at this site remain
constant until late in infection. This finding corroborates a
unique observationmade from the Tn-seq data set, shedding new
light on B. pseudomallei dissemination.
Identification of Virulence Determinants
Required for B. pseudomallei Colonization
of Host Lungs
We initially focused our analysis of the Tn-seq data set on
identifying virulence determinants required by B. pseudomallei
FIGURE 3 | Burkholderia pseudomallei Tn-seq transposon library
tissue burdens at key sites of infection. Groups of three C57BL/6 female
albino mice infected with the B. pseudomallei Tn-seq transposon library were
euthanized at 6, 12, and 24 h post-infection. Bacterial titers in the lungs, liver
and spleen were enumerated by plate counting and compared to bacterial
titers of moribund mice at 66 h post-infection from the initial Tn-seq
transposon library challenge. The limit of detection of bacterial enumeration
from host tissue is indicated by a dashed line. Tissue counts below the limit of
detection were set to the limit of detection for statistical analysis. Statistical
significance was calculated by Two-Way ANOVA followed by Bonferroni
post-test (**P < 0.01; ***P < 0.001; ns, not significant).
to colonize the lungs of mammalian hosts, of which 1455 genes
were required to colonize the murine lung at a 3-fold relative
abundance cutoff ratio relative to the input pool (Figure 2B). As
a refined stringency to focus our identification of key virulence
determinants, we made use of a targeted analysis of the capsular
polysaccharide biosynthetic cluster (CPS or CPS I, Reckseidler-
Zenteno et al., 2009). We have previously demonstrated that a
capsule mutant was attenuated 6.8-fold relative to the isogenic
parent strain in the IMIT model, but that this level of attenuation
was not statistically significant (Gutierrez et al., 2015). We
therefore performed a detailed analysis of the Tn-seq lung results
for CPS biosynthetic cluster as a benchmark genetic system
which exhibits a marginal level of attenuation by LD50 analysis.
We found that while the majority of CPS genes were reduced
in the lung relative to the input pool, pronounced variation
in degree of response was observed across the genetic cluster
(Figure 4). This variation was suggestive of bottlenecking effects
which are possible under the parameters of the current study,
designed for a biologically relevant infection while achieving
saturating library coverage. While variation was observed across
the CPS locus, the locus itself exhibited an average 14.92-fold
reduction in mutant prevalence for the lung vs. input pool.
Thus, to further analyze the Tn-seq lung data set, we set a
more stringent fold-change cut off of 15-fold, reflecting the
magnitude of the average fold gene reduction of the CPS locus.
Further, we decided to identify clusters of genes which meet
this 15-fold cutoff to mitigate the impact which bottlenecking
might have on dataset variation at the individual gene level
(Figure 4).
A total of 548 genes underwent selective pressure in the
lung at a 15-fold cutoff relative to the input pool. These genes
were heat mapped for nearest neighbor relationships (Figure 5)
to identify genetic clusters with consecutive hits of no more
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FIGURE 4 | Analysis of variation within capsular polysaccharide operon genes required for lung colonization by Tn-seq. (A) Scale representation of the
capsular polysaccharide genetic locus. (B) Variation in fold-change of capsule genes by Tn-seq analysis of the lung data set relative to the input pool. The average fold
reduction across all capsule genes was 14.92-fold (dashed horizontal line). *Denotes genes not covered in the input library.
than a 4 gene distance from the previous hit. The three genetic
loci which provided the largest assemblage of genes meeting
these criteria included: (i) CPS (8 genes), (ii) Type 6 Secretion
System cluster 5 (T6SS5; 8 genes), and (iii) Type 3 Secretion
System cluster 3 (T3SS3; 7+5 genes) (Table 2). There are six
distinct T6SS clusters in the B. pseudomallei genome, and the
T6SS5 is identified as cluster 5 by the NCBI database (Shalom
et al., 2007), and this same cluster is identified as cluster 1 in
Burkholderia mallei (Schell et al., 2007). Numerous additional
small genetic clusters may provide important contributions
to the fitness of B. pseudomallei in the lung; however,
these data indicate that the three prominent genetic systems
contributing to B. pseudomallei lung pathogenesis are CPS,
T3SS3, and T6SS5. Given that we have previously characterized
the contribution of CPS and T3SS3 to respiratory melioidosis
using the IMIT model (Gutierrez et al., 2015), we decided to
address what impact the T6SS5 system has on the virulence of
B. pseudomallei.
Only a single gene met the 15-fold cutoff criterion in the
liver (thioredoxin: -16.2-fold liver:input), suggesting that the liver
does not offer a strong selective pressure against B. pseudomallei
relative to that of the lung. Conversely, 2255 genes met this more
stringent 15-fold cutoff criterion in the spleen, thus this criterion
did not effectively reduce the number of hits in the spleen from
the 2862 hits at a 3-fold cutoff criterion. Due to the late spread
to the spleen and the large number of gene hits, we interpret that
the colonization of the spleen in this current model system is a
FIGURE 5 | Proximity heat map of genes required for respiratory
melioidosis. The Tn-seq lung data set was filtered for genes required by
B. pseudomallei at a 15-fold reduction cut off relative to the input pool (548
genes). Genes were sorted for their arrangement on the two circular
chromosomes of the B. pseudomallei genome, with similar distribution density
found on the larger chromosome 1 (309 genes) and smaller chromosome 2
(239 genes). The heat map provides graphical cluster analysis of gene hits
located in close proximity (red = 1 gene distance) or distal hits (green >70
gene neighbor distance). The three largest genetic clusters of hits separated
by no more than 4 genes per hit are indicated: capsular polysaccharide (CPS
I), Type 3 Secretion System cluster 3 (T3SS3), and Type 6 Secretion System
cluster 5 (T6SS5).
bottle-necked event that does not facilitate a biologically relevant
data interpretation. This study therefore focused on validating
the results from the lung dataset, specifically the identification of
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TABLE 2 | Identification of prominent genetic loci required for pulmonary disease.
Feature ID Fold change Distance to previous hit Feature ID Fold change Distance to previous hit
T3SS3 T6SS5
bprA −70.3781 BP1026B_II1587 −83.2298
bipC −35.0191 1 hcp−5 −367.19 4
bipB −15.6668 1 tssF−5 −22.3609 3
bicA −15.2996 1 clpV−5 −23.6294 1
bsaZ −56.991 1 tagB−5 −21.4194 3
spaP −15.6396 3 tagC−5 −22.6434 1
bsaV −26.665 1 tssK−5 −31.7466 2
bsaO −82.8959 7 tssL−5 −111.177 2
BP1026B_II1643 −34.0416 2 Capsule
BP1026B_II1644 −59.6684 1 wcbF −36.6525
BP1026B_II1645 −40.3909 1 wcbG −25.4066 2






capsule, T3SS3 and T6SS5 as the largest genetic loci contributing
to respiratory melioidosis.
T6SS5 Mutant is not Attenuated in the IMIT
Model
We previously calculated the LD50 of a B. pseudomallei
luminescent strain JW280 to be 103.87 CFU, a T3SS3
translocation-deficient mutant, JW280 1sctUBp3 to be 10
6.19
CFU and a CPS operon mutant to be 104.57 (Gutierrez et al.,
2015). While CPS, T3SS3, and T6SS5 all contributed to
B. pseudomallei pulmonary fitness by the Tn-seq screen, single
strain challenge with a CPS mutant did not reveal an attenuation
by LD50, whereas a T3SS3 mutant was significantly attenuated
>200-fold (Gutierrez et al., 2015). We therefore challenged
C57BL/6J albino female mice with 103.95 CFU of the JW280
luminescent strain and 104.25 CFU of the JW280 1tssC-5
luminescent T6SS5 mutant strain to investigate the role of T6SS5
in respiratory melioidosis. Infection with the parent JW280
strain close to its LD50 resulted in 67% mortality (Figure 6A),
whereas infection with the luminescent T6SS5 mutant was 100%
lethal with the 104.25 CFU dose, which is 0.52-log above the
parent LD50. Thus, the LD50 of the tssC-5mutant is<10
4.25 CFU,
which was not significantly attenuated by Log-rank survival
analysis relative to the parent control (Figure 6A). Therefore,
like the CPS mutant, the T6SS5 mutant is not attenuated in
single strain respiratory model challenge. Optical diagnostic
imaging was used to monitor bacterial proliferation in the lung
of lethally infected mice, and by 19 h post-infection, both the
parent and the T6SS5 mutant were detectable by bioluminescent
imaging, however the bioluminescent signal intensity increased
at similar rates in the thoracic cavity (Figure 6B). While the
T6SS5 mutant appeared to be slightly less fit than parent strain
in proliferation rate, this difference was not significant. We
characterized the bacterial tissue burden in moribund mice and
found no significant difference between the T6SS5 and parent
bacterial titers in the lungs, liver and spleen (Figures 6C–E).
Thus, although our Tn-seq analysis revealed that the T6SS5
cluster is required for the full fitness of B. pseudomallei in the
lung, single strain pulmonary challenge studies did not support
this role for T6SS5.
A B. pseudomallei T6SS5 Mutant is
Attenuated in Competition Studies
Given that Tn-seq is a genome-wide competition study, and
initial validation of our Tn-seq results using traditional LD50
estimations did not identify attenuation for the tssC-5 mutant,
we decided to investigate whether this T6SS5 mutant is
attenuated by direct competition studies. We generated a novel
gentamicin-marked PtolCluxCDABE bioluminescence reporter
strain, MGBP001, which we also generated for the CPS,
T3SS3, and T6SS5 mutants, and used these in competition
studies against gentamicin-sensitive, non-luminescent, DD503.
Accordingly, four groups of three C57BL/6J albino female mice
were inoculated with ∼104.0 B. pseudomallei at a 1:1 ratio of
DD503 combined with either: (i) MGBP001, (ii) MGBP001
1wcb (CPS−), (iii) MGBP001 1sctUBp3 (T3SS3-), or (iv)
MGBP001 1tssC-5 (T6SS5-). Infections persisted for 67 h (late
stage disease) before lungs, liver and spleen were collected and
homogenates differentially plated on agar to identify proportions
of gentamicin resistant and sensitive strains. The MGBP001
parent strain exhibited a competition index which was not
significantly different from a ratio of 1.0 (Figure 7A), indicating
that DD503 and MGBP001 shared the same virulence potential
in all tissues, suggesting that neither the luminescence operon
nor gentamicin resistance impact the virulence of the MGBP001
B. pseudomallei parent strain. Interestingly, all three mutant
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FIGURE 6 | In vivo characterization of a T6SS mutant. (A) Survival curve of C57BL/6 female albino mice by IMIT infected with either JW280 or JW280 1tssC-5.
(B) In vivo growth of B. pseudomallei strains JW280 and JW280 1tssC-5 infecting C57BL/6 mice, where bioluminescence was monitored twice per day and thoracic
cavity total flux (p/s) was collected from region of interest measurements. The technical 95% limit of detection is indicated by a horizontal dashed line. Bacterial titers in
the lungs (C), liver (D), and spleen (E) of C57BL/6 mice infected with either JW280 or JW280 1tssC-5 were enumerated by bioluminescence measurements of ex
vivo tissues (counts per second [cps]/tissue), as described (Lawrenz et al., 2014). Statistical significance was calculated using the Student’s T-test (ns: not significant).
strains exhibited significantly reduced competition indices in the
lungs, liver and spleen of mice relative to the non-luminescent
DD503 competition partner (Figure 7A). Furthermore, optical
diagnostic imaging of the thoracic cavity demonstrated that the
parent MGBP001 strain proliferated within the lung (Figure 7B),
consistent with the pulmonary colonization observed by the
JW280 strain (Gutierrez et al., 2015). Imaging was able to
successfully monitor the decreased fitness of the three mutants
in the lung during the course of infection (Figure 7B), with
significant decreases in thoracic cavity bioluminescence for all
but the capsule mutant by 39 h, and for all strains by 50 h.
Thus, optical diagnostic imaging successfully provides an early
indication of fitness defects in vivo during competition studies.
Therefore, CPS, T3SS3, and T6SS5 are all critical virulence
determinants to support the fitness of B. pseudomallei in the lung,
but importantly, attenuation of these virulence systems by single
strain challenge studies has only been able to identify a role for
T3SS3. We propose that competition analyses, including Tn-seq,
provide a higher resolution assay by which to assess the role of
B. pseudomallei virulence determinants in the lung, and that our
current Tn-seq screen successfully identified CPS, T3SS3, and
T6SS5 as the largest genetic loci required to facilitate respiratory
melioidosis.
DISCUSSION
In this study, we performed Tn-seq analysis to identify virulence
determinants required to cause respiratory disease in a mouse
model of lung-specific melioidosis. The primary design criterion
of our screen was achieving the balance of saturating transposon
mutagenesis while also limiting the challenge dose to allow for
a biologically relevant disease progression. Previous transposon-
directed insertion site sequencing and Tn-seq libraries have
been generated in the Burkholderia pseudomallei strain K96243
(Moule et al., 2014) and its close relative Burkholderia
thailandensis (Baugh et al., 2013; Gallagher et al., 2013) to identify
essential genes required for survival of these pathogens in vitro.
Importantly, these in vitro screens allowed formuch larger library
sizes to identify essential genes which were not amenable to
transposonmutagenesis, which for B. pseudomalleiwas estimated
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 November 2015 | Volume 5 | Article 78
Gutierrez et al. Respiratory melioidosis Tn-seq
FIGURE 7 | Burkholderia pseudomallei major virulence determinants
are attenuated in competition assays. (A) Competitive index of
luminescent, Gm-marked parent strain (MGBP001), capsular polysaccharide
deletion mutant (MGBP001 1wcb) and T3SS (MGBP001 1sctUBp3) and
T6SS5 (MGBP001 1tssC-5) mutants compared to Gm-sensitive,
non-luminescent strain, DD503. Competitive index was calculated as the
output ratio of mutant to parent divided by the input ratio of mutant to parent,
having differentially plated lung, liver and spleen homogenates on agar plates
with or without gentamicin selection. The horizontal dashed line indicates a
competitive index of 1. Statistical significance was calculated using One-Way
ANOVA followed by Tukey’s Multiple Comparison Test (*P < 0.01; **P < 0.001;
***P < 0.0001).(B) In vivo growth of MGBP001, MGBP001 1wcb, MGBP001
1sctUBp3,MGBP001 1tssC-5 in the lungs was monitored twice daily using
luminescence as a read out for bacterial replication, and total flux (p/s)
measurements collected from regions of interest centered on the thoracic
cavity. The horizontal dashed line indicates the 95% technical limit of detection.
to be 8.0% of the genome (Moule et al., 2014). In spite of
limiting library size in our study to allow for infection studies,
we achieved coverage of 88% of the 6141 estimated genes, where
the theoretical maximum coverage is 92% based on estimates of
number for essential genes. While our Tn-seq library was not
designed to identify essential genes, we performed a ortholog
search of the B. pseudomallei K96243 TraDIS-identified essential
genes (Moule et al., 2014), and of the 483 orthologs in the 1026b
genome, 53 genes were similarly identified with no reads in our
Tn-seq library. An additional 202 K96243 essential orthologs
were low read hits in our Tn-seq data set at one standard
deviation below the log transformed mean read density. Thus,
our Tn-seq data set confirms ∼53% of the essential genes in
the K96243 TraDIS essential gene list as confirmed essential
genes in 1026b orthologs. The remaining half of the predicted
essential genes were successfully read in our Tn-seq dataset, and
we propose that these are not essential genes in 1026b, including
such systems as Type 3 Secretion System cluster 1 (T3SS1) and
three of the Type 6 Secretion Systems (T6SS2, T6SS4, and T6SS5),
notably including T6SS5 which was a subject of investigation in
these studies. Thus, consistent with the wider body of literature,
some of the genes previously reported as essential may not be so,
notably including the report that amrA and amrB are essential
genes (Moule et al., 2014); while we do not read these genes in
our Tn-seq dataset due to the fact that they have been deleted
from DD503-linage strains, these are clearly not essential genes
due to the availability of strains lacking these genes (Moore
et al., 1999). These findings may suggest that the essential gene
repertoire of B. pseudomallei is smaller than previously reported,
and may reflect contributions from differences in strain (K96243
vs. 1026b lineage), transposon (Tn5 vs. Marineer) and other
potential culturing techniques.
An unexpected result of our Tn-seq dataset was the revelation
that B. pseudomallei is capable of reaching the liver very early in
the course of infection, which was subsequently validated by a
time course infection study. These findings were facilitated by
using IMIT instillation which has been reported to efficiently
deliver<98% of an instilled dose directly into the lung (Lawrenz
et al., 2014). Within 6 h of delivery directly into the lung by IMIT
instillation, B. pseudomallei not only replicates in the lung, but
also spreads to the liver at numbers similar to that cultured from
the lung. Interestingly, few genes were critical for B. pseudomallei
to maintain a presence in the liver, relative to the lung, suggesting
that the lung does not persistently seed the liver over the course of
infection, nor is the liver a source of a strong selective pressure to
B. pseudomallei. Furthermore, B. pseudomallei does not appear
to replicate in the liver until late in the infection, suggesting
that the systemic fitness of the host may impact the replication
potential of B. pseudomallei in the liver, again given that Tn-
seq results do not support the possibility that the late infection
increase in hepatic burden results from spread from the lung. It
is noteworthy that in other respiratory models, the liver becomes
colonized at later time points; for instance, aerosol delivery of
B. pseudomallei did not result in detection of bacteria in the
liver until 3 days post-infection (Tan et al., 2008). Thus, the
observation of rapid dissemination from the lung to the liver
may be a unique feature of the IMIT model, as is the prominent
moribund septicemia which is not observed in other respiratory
melioidosis models. Future work will be required to understand
the role of the liver as a replicative niche for B. pseudomallei
during respiratory melioidosis.
We developed a high specificity filter to prioritize follow-up
analysis of the Tn-seq results of the lung. The selection criteria
was benchmarked to the capsule polysaccharide genetic locus
which we previously demonstrated was not a critical virulence
determinant in the IMIT model of respiratory melioidosis, yet
was attenuated 6.8-fold relative to parent (Gutierrez et al., 2015).
Thus, our criteria was chosen to capture all virulence systems,
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including those which may not be significantly required by
LD50 analysis. Our screen identified 548 genes, 8.7% of the
genome’s predicted ORFs, to be required by the bacterium
for mammalian lung colonization, and of these, 32% (175
ORFs) accounted for hypothetical proteins, suggesting that
additional novel virulence systems may participate in mediating
fitness within the mammalian lung. Using cluster analysis to
further prioritize the Tn-seq data set, we identified the three
dominant genetic loci contributing to respiratory melioidosis as
CPS, T3SS3, and T6SS5. Interestingly, these systems have been
previously identified as virulence systems in systemic animal
models (Reckseidler et al., 2001; Warawa and Woods, 2005;
Burtnick et al., 2011); however, other virulence determinants
described as important in systemic disease models did not meet
our selection criteria, including the lipopolysaccharide (LPS)
biosynthetic locus which had just two genes meeting our 15-
fold selection criterion. Thus, virulence determinants required
to support systemic infection may not be the same as those
required in the lung. Our Tn-seq analysis was notably biased to
the identification of large genetic systems which contribute to
respiratory melioidosis, and it is therefore likely that additional
smaller genetic loci have also been identified by this Tn-seq
dataset, which will be the subject of future investigation.
Most B. pseudomallei virulence factors have been
characterized primarily in systemic infection models, including
intravenous, subcutaneous, and intraperitoneal inoculation.
Indeed, the three major virulence systems targeted from our Tn-
seq screen have been well studied as major contributors to disease
in hamster and mouse systemic intraperitoneal infection models.
The capsular polysaccharide has been characterized by several
groups as providing one of the most significant contributions to
the systemic disease potential of B. pseudomallei, with capsule
mutants being attenuated ∼5 log in these infection models
(Atkins et al., 2002; Reckseidler-Zenteno et al., 2005). The
significant role for capsule in B. pseudomallei systemic disease
is consistent with a demonstrated role of this virulence factor in
resisting complement opsonization of the bacteria (Reckseidler-
Zenteno et al., 2005), and therefore likely a critical virulence
factor for traffic between tissues, suggestive of B. pseudomallei
spread as an extracellular pathogen. Interestingly, the capsule
mutant does not appear to have a major role in the respiratory
system of mice by single strain challenge, with attenuation
levels of <2 log by intranasal delivery and <1 log by IMIT
instillation (Warawa et al., 2009; Gutierrez et al., 2015). The
T3SS3 system is known to importantly allow for escape of
B. pseudomallei from phagosomes to facilitate rapid replication
in the cytoplasm of phagocytes (Stevens et al., 2002), and the
ubiquitous requirement for T3SS3 in both systemic (Warawa and
Woods, 2005) and respiratory disease models (Gutierrez et al.,
2015) suggests that the intracellular lifestyle of B. pseudomallei
is critical in all host tissues. Indeed, T3SS3 is the only virulence
system examined thus far in the IMIT instillation method
which exhibits significant attenuation by single strain challenge,
suggesting that this virulence system is one of the most critical
systems for both respiratory and systemic disease. The primary
function of the T6SS5 system is not well described, though
there is evidence that T6SS5 supports the intracellular lifestyle
of B. pseudomallei and cell-to cell spread (Pilatz et al., 2006;
Burtnick et al., 2011). T6SS5 system mutants are attenuated
>3 log in a systemic hamster intraperitoneal model (Burtnick
et al., 2011) and are attenuated ∼2–3 log in intranasal murine
models (Pilatz et al., 2006; Hopf et al., 2014). In this current
study, the role for T6SS5 in respiratory melioidosis in single
strain challenges using IMIT delivery does not appear to suggest
a prominent role given that we were unable to demonstrate
significant attenuation in single strain challenge studies, which
is in contrast to what has been previously reported for the
intranasal models. We have previously demonstrated that
intranasal inoculation of B. pseudomallei in mice results in
a moribund disease state primarily associated with the nasal
cavity rather than the systemic disease state observed following
IMIT inoculation (Gutierrez et al., 2015). Thus, T6SS5 may be
an important factor for nasal cavity colonization, but does not
play the same critical role in the lung as seen for the T3SS3
system. In spite of the inability of capsule and T6SS5 mutants to
demonstrate T3SS3-like significant attenuation by single strain
challenges, they are clearly virulence determiants when assessed
in competition studies.
A technical caveat of these studies relates to the use
of a cloning strain of B. pseudomallei to perform the Tn-
seq screen. The Tn-seq library was developed using the
JW280 bioluminescent strain, which was derived from the
aminoglycoside-sensitive strain DD503, which is itself derived
from the 1026b clinical isolate. We have previously demonstrated
that the introduction of the luxCDABE bioluminescent operon
into the B. pseudomallei genome did not impact the virulence of
the bacteria (Warawa et al., 2011), which was validated in this
study by the finding that introduction of both luxCDABE and
the gentamicin resistance marker (MGBP001) did not impact
the competition index relative to the parent strain, DD503. It is
important to note that the deletion of the AmrAB-OprA eﬄux
pump in the DD503 strain may have an impact on virulence of
B. pseudomallei and thus impact which genes are required for
lung fitness in that specific strain background.
A key finding of our studies was the ability of competition
studies to provide a higher resolution identification of virulence
factors in the fitness of B. pseudomallei in the lung than
single strain challenges/LD50 analyses. Similar findings have
been made for other disease model systems, where competition
index provides a higher resolution methodology for defining
the contribution of virulence genes to a pathogen’s fitness in
animal model systems (Auerbuch et al., 2001; Logsdon and
Mecsas, 2003; Yang et al., 2012). We had previously reported
that a CPS mutant was not significantly attenuated by LD50
in the IMIT model (Gutierrez et al., 2015), but presently that
CPS was significantly attenuated by competition study in the
IMIT model. Similarly, we were unable to validate a significant
attenuation for a T6SS5 mutant by single strain challenge, but
identified a significant attenuation by competition index. The
Tn-seq screen itself is a genome wide competition assay, thus
our competition studies were able to successfully recapitulate the
phenotypes we identified from the Tn-seq screen results, whereas
single strain challenges did not have the resolution to defined
roles in respiratory melioidosis to either capsular polysaccharide
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or T6SS5. These observations indicate that competition studies
have a higher resolution to ascribe roles in virulence to both CPS
and T6SS5 in respiratory melioidosis, and thus far, T3SS3 is the
sole virulence determinant which exhibits attenuation by LD50 in
the IMIT respiratory melioidosis model (Gutierrez et al., 2015).
As an added feature of our competition assay, we have included
a unique optical imaging approach which is further capable of
detecting significant fitness defects in competition studies as early
as 39 h post-infection.
An additional aspect of these studies worth highlighting
is the finding that significant phenotypes were able to be
resolved using small group sizes of animals. The three Rs
of responsible animal research include: (1) replacement, (2)
reduction, and (3) refinement; it is notable that reduction in
group size was achievable through the methods we employed.
By using groups of three mice inoculated by IMIT inoculation
and infection monitoring by bioluminescence, we are successful
in very targeted, efficient delivery of reagents directly into the
lung (Lawrenz et al., 2014), which reduces variation in study
metrics. This was particularly apparent in the demonstrated
ability to synchronize infections and achieve excellent bacterial
burden analysis throughout our studies. Most host-pathogen
interactions are successfully studied by triplicate analysis, and we
have demonstrated that n = 3 studies can be successfully carried
out using whole animal host-pathogen interaction studies as well.
This is consistent also with the previous use of small groups of
animals (3–4 animals) to perform pooled in vivo Tn-seq analysis,
and such study design has successfully resolved the detection of
virulence systems for other bacterial pathogens (Skurnik et al.,
2013a,b; Wang et al., 2014).
In summary, we provide the first phenotypic screen for
B. pseudomallei virulence factor function in the mammalian
lung, and have identified the largest critical genetic systems
as CPS, T3SS3, and T6SS5. While previously identified as
virulence systems, this study represents the first comparative
study to validate their importance to respiratory melioidosis.
These virulence systems therefore represent excellent targets for
the future development of therapeutics against this Tier 1 Select
Agent pathogen.
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